新型维生素D受体-共激活因子抑制剂的研发
Development of novel Vitamin D Receptor-Coactivator Inhibitors.
作者信息
Sidhu Preetpal S, Nassif Nicholas, McCallum Megan M, Teske Kelly, Feleke Belaynesh, Yuan Nina Y, Nandhikonda Premchendar, Cook James M, Singh Rakesh K, Bikle Daniel D, Arnold Leggy A
机构信息
Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, WI 53211, USA.
Molecular Therapeutics Laboratory, Program in Women's Oncology, Department of Obstetrics and Gynecology, Woman and Infant's Hospital of Rhode Island, Alpert Medical School of, Brown University, Provence, Rhode Island, USA.
出版信息
ACS Med Chem Lett. 2014 Feb 13;5(2):199-204. doi: 10.1021/ml400462j.
Abstract
Nuclear receptor coregulators are master regulators of transcription and selectively interact with the vitamin D receptor (VDR) to modulate cell differentiation, cell proliferation and calcium homeostasis. Herein, we report the syntheses and evaluation of highly potent and selective VDR-coactivator inhibitors based on a recently identified 3-indolylmethanamine scaffold. The most active compound, PS121912, selectively inhibited VDR-mediated transcription among eight other nuclear receptors tested. PS121912 is also selectively disrupting the binding between VDR and the third nuclear receptor interaction domain of the coactivator SRC2. Genetic studies revealed that PS121912 behaves like a VDR antagonist by repressing 1,25-(OH)D activated gene transcription. In addition, PS121912 induced apoptosis in HL-60.
摘要
核受体共调节因子是转录的主要调节因子，可与维生素D受体（VDR）选择性相互作用，以调节细胞分化、细胞增殖和钙稳态。在此，我们报告了基于最近鉴定的3-吲哚基甲胺支架的高效和选择性VDR共激活剂抑制剂的合成与评价。活性最高的化合物PS121912在测试的其他八种核受体中选择性抑制VDR介导的转录。PS121912还选择性地破坏VDR与共激活剂SRC2的第三个核受体相互作用域之间的结合。遗传学研究表明，PS121912通过抑制1,25-(OH)D激活的基因转录，表现得像一种VDR拮抗剂。此外，PS121912诱导HL-60细胞凋亡。
相似文献
1
Development of novel Vitamin D Receptor-Coactivator Inhibitors.新型维生素D受体-共激活因子抑制剂的研发
ACS Med Chem Lett. 2014 Feb 13;5(2):199-204. doi: 10.1021/ml400462j.
2
Anticancer activity of VDR-coregulator inhibitor PS121912.维生素D受体共调节因子抑制剂PS121912的抗癌活性
Cancer Chemother Pharmacol. 2014 Oct;74(4):787-98. doi: 10.1007/s00280-014-2549-y. Epub 2014 Aug 9.
3
Discovery of the first irreversible small molecule inhibitors of the interaction between the vitamin D receptor and coactivators.发现维生素 D 受体与共激活因子相互作用的首个不可逆小分子抑制剂。
J Med Chem. 2012 May 24;55(10):4640-51. doi: 10.1021/jm300460c. Epub 2012 May 16.
4
The vitamin D hormone and its nuclear receptor: molecular actions and disease states.维生素D激素及其核受体：分子作用与疾病状态。
J Endocrinol. 1997 Sep;154 Suppl:S57-73.
5
Peroxisome proliferation-activated receptor δ agonist GW0742 interacts weakly with multiple nuclear receptors, including the vitamin D receptor.过氧化物酶体增殖物激活受体 δ 激动剂 GW0742 与多种核受体（包括维生素 D 受体）弱相互作用。
Biochemistry. 2013 Jun 18;52(24):4193-203. doi: 10.1021/bi400321p. Epub 2013 Jun 10.
6
Calmodulin-dependent kinase IV stimulates vitamin D receptor-mediated transcription.钙调蛋白依赖性激酶IV刺激维生素D受体介导的转录。
Mol Endocrinol. 2005 Sep;19(9):2309-19. doi: 10.1210/me.2004-0382. Epub 2005 May 26.
7
Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction.维生素D受体激活转录及共激活因子相互作用中AF-2结构域依赖配体的分子内折叠的证据。
Mol Endocrinol. 1997 Sep;11(10):1507-17. doi: 10.1210/mend.11.10.9990.
8
Novel VDR antagonists based on the GW0742 scaffold.基于GW0742支架的新型维生素D受体拮抗剂。
Bioorg Med Chem Lett. 2018 Feb 1;28(3):351-354. doi: 10.1016/j.bmcl.2017.12.041. Epub 2017 Dec 19.
9
The 1,25(OH)2D3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation.1,25-二羟维生素D3调节的转录因子MN1刺激维生素D受体介导的转录并抑制成骨细胞增殖。
Mol Endocrinol. 2005 Sep;19(9):2234-44. doi: 10.1210/me.2005-0081. Epub 2005 May 12.
10
Increased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cells.强心甾类化合物蟾毒灵在人髓性白血病细胞中增强维生素D受体的核表达及反式激活作用
J Steroid Biochem Mol Biol. 2009 Apr;114(3-5):144-51. doi: 10.1016/j.jsbmb.2009.01.022. Epub 2009 Feb 6.
引用本文的文献
1
Comparative Analyses of the Safety Profiles of Vitamin D Receptor Agonists: A Pharmacovigilance Study Based on the EudraVigilance Database.维生素D受体激动剂安全性概况的比较分析：一项基于欧洲药物警戒数据库的药物警戒研究
Pharmaceuticals (Basel). 2024 Dec 13;17(12):1686. doi: 10.3390/ph17121686.
2
Enantioselective synthesis of α-tetrasubstituted (1-indolizinyl) (diaryl)-methanamines chiral phosphoric acid catalysis.手性磷酸催化对映选择性合成α-四取代（1-中氮茚基）（二芳基）甲胺
RSC Adv. 2024 Jan 2;14(2):1106-1113. doi: 10.1039/d3ra07636a.
3
Enantioselective synthesis of α-tetrasubstituted (3-indolizinyl) (diaryl)methanamines chiral phosphoric acid catalysis.手性磷酸催化对映选择性合成α-四取代（3-中氮茚基）（二芳基）甲胺
RSC Adv. 2022 Jul 15;12(32):20499-20506. doi: 10.1039/d2ra03750e. eCollection 2022 Jul 14.
4
Developmental exposure of zebrafish to vitamin D receptor acting drugs and environmental toxicants disrupts behavioral function.发育暴露于维生素 D 受体作用药物和环境毒物会破坏斑马鱼的行为功能。
Neurotoxicol Teratol. 2020 Sep-Oct;81:106902. doi: 10.1016/j.ntt.2020.106902. Epub 2020 May 27.
5
Vitamin D Stimulates Cardiomyocyte Proliferation and Controls Organ Size and Regeneration in Zebrafish.维生素 D 可刺激心肌细胞增殖，并控制斑马鱼的器官大小和再生。
Dev Cell. 2019 Mar 25;48(6):853-863.e5. doi: 10.1016/j.devcel.2019.01.001. Epub 2019 Jan 31.
6
Alternative binding sites at the vitamin D receptor and their ligands.维生素 D 受体的替代结合位点及其配体。
Mol Cell Endocrinol. 2019 Apr 5;485:1-8. doi: 10.1016/j.mce.2019.01.011. Epub 2019 Jan 14.
7
Confirmation of high-throughput screening data and novel mechanistic insights into VDR-xenobiotic interactions by orthogonal assays.通过正交测定法确认高通量筛选数据和新型 VDR-异生物质相互作用的机制见解。
Sci Rep. 2018 Jun 11;8(1):8883. doi: 10.1038/s41598-018-27055-3.
8
Novel VDR antagonists based on the GW0742 scaffold.基于GW0742支架的新型维生素D受体拮抗剂。
Bioorg Med Chem Lett. 2018 Feb 1;28(3):351-354. doi: 10.1016/j.bmcl.2017.12.041. Epub 2017 Dec 19.
9
Pharmacological use of a novel scaffold, anomeric N,N-diarylamino tetrahydropyran: molecular similarity search, chemocentric target profiling, and experimental evidence.新型支架——端基 N,N-二芳基氨基四氢吡喃的药理学用途：分子相似性搜索、基于化学的靶标分析和实验证据。
Sci Rep. 2017 Oct 2;7(1):12535. doi: 10.1038/s41598-017-12082-3.
10
Inhibitors for the Vitamin D Receptor-Coregulator Interaction.维生素D受体-共调节因子相互作用的抑制剂
Vitam Horm. 2016;100:45-82. doi: 10.1016/bs.vh.2015.10.002. Epub 2015 Nov 30.
本文引用的文献
1
Peroxisome proliferation-activated receptor δ agonist GW0742 interacts weakly with multiple nuclear receptors, including the vitamin D receptor.过氧化物酶体增殖物激活受体 δ 激动剂 GW0742 与多种核受体（包括维生素 D 受体）弱相互作用。
Biochemistry. 2013 Jun 18;52(24):4193-203. doi: 10.1021/bi400321p. Epub 2013 Jun 10.
2
Beyond the ligand-binding pocket: targeting alternate sites in nuclear receptors.超越配体结合口袋：靶向核受体中的替代结合位点。
Med Res Rev. 2013 Sep;33(5):1081-118. doi: 10.1002/med.21275. Epub 2012 Nov 26.
3
Structure-activity relationship of benzodiazepine derivatives as LXXLL peptide mimetics that inhibit the interaction of vitamin D receptor with coactivators.苯二氮䓬衍生物作为 LXXLL 肽模拟物的结构-活性关系，抑制维生素 D 受体与共激活剂的相互作用。
Bioorg Med Chem. 2013 Feb 15;21(4):993-1005. doi: 10.1016/j.bmc.2012.11.042. Epub 2012 Dec 5.
4
Discovery of the first irreversible small molecule inhibitors of the interaction between the vitamin D receptor and coactivators.发现维生素 D 受体与共激活因子相互作用的首个不可逆小分子抑制剂。
J Med Chem. 2012 May 24;55(10):4640-51. doi: 10.1021/jm300460c. Epub 2012 May 16.
5
A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution.一项 ChIP-seq 定义的维生素 D 受体结合的全基因组图谱：与疾病和进化的关联。
Genome Res. 2010 Oct;20(10):1352-60. doi: 10.1101/gr.107920.110. Epub 2010 Aug 24.
6
A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumors.一项口服给予晚期实体瘤患者维生素 D3 类似物 ILX23-7553 的 I 期研究。
Invest New Drugs. 2011 Dec;29(6):1420-5. doi: 10.1007/s10637-010-9492-5. Epub 2010 Jul 27.
7
LXXLL peptide mimetics as inhibitors of the interaction of vitamin D receptor with coactivators.LXXLL 肽模拟物作为维生素 D 受体与共激活因子相互作用的抑制剂。
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1712-7. doi: 10.1016/j.bmcl.2010.01.079. Epub 2010 Jan 21.
8
A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.一类新型维生素 D 类似物，可诱导受体配体结合口袋的结构重排。
J Med Chem. 2009 Mar 12;52(5):1438-49. doi: 10.1021/jm8014348.
9
Quantification of the vitamin D receptor-coregulator interaction.维生素D受体-共调节因子相互作用的定量分析。
Biochemistry. 2009 Feb 24;48(7):1454-61. doi: 10.1021/bi801874n.
10
High-throughput system for analyzing ligand-induced cofactor recruitment by vitamin D receptor.用于分析维生素D受体配体诱导的辅因子募集的高通量系统。
Bioconjug Chem. 2007 May-Jun;18(3):614-20. doi: 10.1021/bc0601121. Epub 2007 Apr 5.
Zotero 插件